Instead of effect sizes of 100 % for proganulin levels, we ask you to provide effect sizes of 20 - 30 % change for power calculations in
progranulin brain levels for Figure 3 to determine whether the power value is > 0.70.
Not exact matches
Our study demonstrates that
progranulin deficiency may promote Alzheimer's disease, with decreased
levels rendering the
brain vulnerable to amyloid - beta toxicity.»
When
progranulin levels are low,
brain cells die more readily when exposed to toxins.
The team, led by Li and her postdoctoral fellow S. Sakura Minami, PhD, showed that low
levels of
progranulin in the
brain lead to symptoms that mimic AD in mice.
SAN FRANCISCO, CA — Researchers at the Gladstone Institutes have shown that low
levels of the protein
progranulin in the
brain can increase the formation of amyloid - beta plaques (a hallmark of Alzheimer's disease), cause neuroinflammation, and worsen memory deficits in a mouse model of this condition.
Brain progranulin protein
levels were measured in all cases by ELISA, and plasma
progranulin protein was measured by western blot.
To test the hypothesis that exercise could increase
brain progranulin levels in Grn + / − mice, we solo - housed 6 - month - old wild - type (Grn + / +), Grn + / −, and Grn − / − mice in standard mouse cages or cages with running wheels for 7.5 weeks.
Greater running distance in the 2 - to 3 - month - old mice may partially explain these data, but the solo - housed wild - type mice used to test solo - versus group - housing (Fig. 5) ran similar distances as the young mice, yet did not show any increase in
brain progranulin levels.
Because the SD of
brain progranulin in wild - type mice was about 10 % of the mean
level,
progranulin levels in Grn + / − mice would need to increase from 50 % of normal to 80 % of normal, i.e. by 30 % of the normal value, to reach the lower limit of normal.
Only Grn + / − mice were included in this group because the primary goal of this experiment was to determine if exercise were capable of increasing
brain progranulin levels in Grn + / − mice.
This study does not support the idea of exercise as a strategy to raise
brain progranulin levels in symptomatic patients with FTD due to GRN mutations, as we observed no effects on
progranulin levels in Grn + / − mice at 4 — 8 months of age, the age range in which these mice begin to develop abnormal behavior and neuronal dysfunction (Filiano et al., 2013).
We housed wild - type and
progranulin - insufficient mice in standard cages or cages with exercise wheels for 4 or 7.5 weeks, and then measured
brain and plasma
progranulin levels.